In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's
In an effort to boost sales of Optison, Amersham Health has begun a new promotional campaign and is focusing on educational efforts aimed at expanding awareness and use of the echocardiography agent. The new campaign follows on the heels Mallinckrodt's recent decision to terminate comarketing rights with Amersham regarding Optison.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).